Healthcare Supply Chain Management Market by Offering (Suite, Analytics, RFID), Function (Procurement, Sourcing, Order Management, Warehouse, Transportation), Managed (Vaccines, CGT), End User (Medical Devices, Pharma), & Region - Global Forecast to 2030
The global healthcare supply chain management market is projected to reach USD 5.06 billion by 2030 from USD 3.71 billion in 2024, at a CAGR of 6.4% during the forecast period. The market is expected to grow as strict regulatory and compliance demands encourage healthcare organizations to implement advanced supply chain management solutions to adhere to safety standards. Increasing healthcare expenses and the necessity for operational efficiency are also motivating the adoption of systems that enhance inventory management, minimize waste, and reduce operational costs. The shortage of skilled professionals managing complex supply chain systems makes implementation and operation more difficult. Additionally, the varying regional regulations also create challenges for internationally operating companies.
“The pharmaceutical & biotechnology segment is expected to register fastest growth during the forecast period, by product managed”
The healthcare supply chain management, by product managed segment, is segmented into pharmaceutical & biotechnology, medical devices & equipment, and others. The pharmaceutical & biotechnology segment is expected to grow the fastest during the forecast period due to the increasing demand for innovative drugs and vaccines driven by rising chronic diseases and an aging population. Advances in biotechnology, such as gene therapies and personalized medicine, add to the growth by creating complex supply chain needs. Additionally, increased concern to address global health issues combined with the imperative to quickly and compliantly distribute urgently needed medicines continues to facilitate this segment's growth.
“On-premise segment dominated the market in the healthcare supply chain management market, by deployment model in 2023.”’
By deployment model, the healthcare supply chain management market is divided into the on-premise models and cloud based models. In 2023, on-premise models accounted to hold a significant share of the healthcare supply chain management market, by deployment model. This segment's prominent position is due to the need to secure private and confidential data and control information workflow in the organization. The absence of incremental costs throughout the ownership of solutions compared to cloud-based deployment also drives the adoption of on-premises solutions. Additionally, internet penetration, ease of access, online documentation, the need for security requirements, and in-house hosting options are the key factors encouraging the growth of the on-premises healthcare supply chain management software market.
“Asia Pacific is expected to register the fastest market growth during the forecast period.”
The healthcare supply chain management market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is anticipated to experience the fastest growth during the forecast period. This rapid expansion can be attributed to government initiatives in the region focused on enhancing healthcare infrastructure and fostering digital transformation. This has resulted in the development of more efficient and resilient supply chains. India's National Digital Health Mission (NDHM) aims to create a strong digital health ecosystem that boosts accessibility, quality, and efficiency in healthcare delivery while enhancing healthcare supply chain management.
The break-down of primary participants is as mentioned below:
The report analyzes the healthcare supply chain management market and aims to estimate the market size and future growth potential of various market segments based on offering, function, product managed, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total healthcare supply chain management market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
“The pharmaceutical & biotechnology segment is expected to register fastest growth during the forecast period, by product managed”
The healthcare supply chain management, by product managed segment, is segmented into pharmaceutical & biotechnology, medical devices & equipment, and others. The pharmaceutical & biotechnology segment is expected to grow the fastest during the forecast period due to the increasing demand for innovative drugs and vaccines driven by rising chronic diseases and an aging population. Advances in biotechnology, such as gene therapies and personalized medicine, add to the growth by creating complex supply chain needs. Additionally, increased concern to address global health issues combined with the imperative to quickly and compliantly distribute urgently needed medicines continues to facilitate this segment's growth.
“On-premise segment dominated the market in the healthcare supply chain management market, by deployment model in 2023.”’
By deployment model, the healthcare supply chain management market is divided into the on-premise models and cloud based models. In 2023, on-premise models accounted to hold a significant share of the healthcare supply chain management market, by deployment model. This segment's prominent position is due to the need to secure private and confidential data and control information workflow in the organization. The absence of incremental costs throughout the ownership of solutions compared to cloud-based deployment also drives the adoption of on-premises solutions. Additionally, internet penetration, ease of access, online documentation, the need for security requirements, and in-house hosting options are the key factors encouraging the growth of the on-premises healthcare supply chain management software market.
“Asia Pacific is expected to register the fastest market growth during the forecast period.”
The healthcare supply chain management market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is anticipated to experience the fastest growth during the forecast period. This rapid expansion can be attributed to government initiatives in the region focused on enhancing healthcare infrastructure and fostering digital transformation. This has resulted in the development of more efficient and resilient supply chains. India's National Digital Health Mission (NDHM) aims to create a strong digital health ecosystem that boosts accessibility, quality, and efficiency in healthcare delivery while enhancing healthcare supply chain management.
The break-down of primary participants is as mentioned below:
- By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
- By Designation - Directors: 30%, Manager: 34%, and Others: 36%
- By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%
- Oracle (US)
- SAP SE (Germany)
- Infor (US)
- IBM (US)
- Mckesson Corporation (US)
- Tecsys Inc. (Canada)
- Global Healthcare Exchange, LLC. (US)
- Cardinal Health. (US)
- Corcentric, Inc. (US)
- Epicor Software Corporation (US)
- Coupa. (US)
- Manhattan Associates (US)
- Blue Yonder Group, Inc. (US)
- LogiTag Systems (US)
- Premier (US)
- Workday, Inc. (US)
- Arvato Systems (Germany)
- GEP (US)
- AmerisourceBergen Corporation. (US)
- Procurement Partners (US)
- Vizient Inc. (US)
- Jump Technologies, Inc. (US)
- inBeam Technologies. (US)
- ConnectSx (US)
The report analyzes the healthcare supply chain management market and aims to estimate the market size and future growth potential of various market segments based on offering, function, product managed, deployment model, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total healthcare supply chain management market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
- Analysis of key drivers (increasing pressure on healthcare providers to improve operational efficiency and profitability, rising demand for healthcare services due to population growth and aging demographics, surging focus on cost reduction within the supply chain, demand for transparency and traceability, continuous support in the form of funding, investment, and partnerships, large scale drug counterfeiting in pharmaceutical industry), restraints (high implementation costs for advanced technologies, data security and privacy concerns), opportunities (adoption of advanced technologies like AI, IoT, and blockchain, expansion into emerging markets with growing healthcare demands, expansion of e-commerce in healthcare, enhanced focus on sustainability and eco-friendly practices in healthcare logistics), challenges (complex and varying regulatory requirements across regions, shortage of skilled professionals to manage sophisticated systems) are factors contributing the growth of the healthcare supply chain management market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the Healthcare supply chain management market.
- Market Development: Comprehensive information on the lucrative emerging markets, offering, function, product managed, deployment model, end user, and region.
- Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the healthcare supply chain management market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Healthcare supply chain management market such as Oracle (US), SAP SE (Germany), Infor (US), IBM (US), Cardinal Health (US).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources for secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Objectives of primary research
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE SHARE ANALYSIS
2.2.2 BOTTOM-UP APPROACH (END-USER ADOPTION)
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.4 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET OVERVIEW
4.2 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER & COUNTRY (2023)
4.3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT
4.4 REGIONAL MIX: HEALTHCARE SUPPLY CHAIN MANAGEMENT (2024?2030)
4.5 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing pressure on healthcare providers to improve operational efficiency and profitability
5.2.1.2 Rising demand for healthcare services due to population growth and aging demographics
5.2.1.3 Focus on reducing supply chain costs
5.2.1.4 Demand for transparency and traceability
5.2.1.5 Availability of funding, investments, and partnerships
5.2.1.6 Large-scale drug counterfeiting in pharmaceutical industry
5.2.2 RESTRAINTS
5.2.2.1 High implementation costs for advanced technologies
5.2.2.2 Data security and privacy concerns
5.2.2.3 Supply chain disruptions due to global events or geopolitical tensions
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing use of AI-powered solutions
5.2.3.2 Expansion into emerging markets with growing healthcare demands
5.2.3.3 Expansion of E-commerce in healthcare
5.2.3.4 Enhanced focus on sustainability and eco-friendly practices
in healthcare logistics
5.2.4 CHALLENGES
5.2.4.1 Complex and varying regulatory requirements across regions
5.2.4.2 Shortage of skilled professionals to manage sophisticated systems
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4 INDUSTRY TRENDS
5.4.1 ERP IN HEALTHCARE SUPPLY CHAIN MANAGEMENT SOLUTIONS
5.4.2 CLOUD-BASED SOLUTIONS
5.4.3 RISING STRATEGIC INITIATIVES AND INNOVATIONS BY KEY
INDUSTRY PLAYERS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Blockchain
5.7.1.2 Artificial intelligence & machine learning
5.7.1.3 Cloud computing
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Data analytics
5.7.2.2 Internet of Things
5.7.3 ADJACENT TECHNOLOGIES
5.7.3.1 AR/VR
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
5.8.2 REGULATORY SCENARIO
5.8.3 INCREASING REGULATIONS AROUND CALIBRATION & CERTIFICATION
5.9 PRICING ANALYSIS
5.9.1 INDICATIVE PRICING OF SOLUTIONS, BY KEY PLAYER
5.9.2 AVERAGE SELLING PRICE, BY REGION (QUALITATIVE)
5.10 PORTER’S FIVE FORCES ANALYSIS
5.10.1 INTENSITY OF COMPETITIVE RIVALRY
5.10.2 BARGAINING POWER OF BUYERS
5.10.3 THREAT OF SUBSTITUTES
5.10.4 THREAT OF NEW ENTRANTS
5.10.5 BARGAINING POWER OF SUPPLIERS
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2 KEY BUYING CRITERIA
5.12 PATENT ANALYSIS
5.12.1 PATENT PUBLICATION TRENDS
5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT
5.12.3 MAJOR PATENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
5.13 END-USER ANALYSIS
5.13.1 UNMET NEEDS
5.13.2 END-USER EXPECTATIONS
5.14 KEY CONFERENCES & EVENTS, 2024–2025
5.15 CASE STUDY ANALYSIS
5.15.1 CASE STUDY 1: TRANSFORMING SUPPLY CHAIN AT DAYTON
CHILDREN’S HOSPITAL
5.15.2 CASE STUDY 2: OLYMPUS CORPORATION’S PATH TO EFFICIENT HEALTHCARE SUPPLY CHAIN MANAGEMENT
5.15.3 CASE STUDY 3: IMPROVING SUPPLY CHAIN EFFICIENCY BY OVERCOMING FORECASTING AND INVENTORY BARRIERS
5.16 INVESTMENT AND FUNDING SCENARIO
5.17 BUSINESS MODELS
5.18 TRADE ANALYSIS
5.18.1 IMPORT SCENARIO FOR HS CODE 847190
5.18.2 EXPORT SCENARIO FOR HS CODE 847190
5.19 IMPACT OF AI/GEN AI ON HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
5.19.1 KEY USE CASES
5.19.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
5.19.2.1 Case Study 1: Enhancing supply chain with AI solutions at NHS Blood and Transplant
5.19.2.2 Case Study 2: Leveraging AI for proactive infection prevention in hospitals
5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.19.3.1 Healthcare IT market
5.19.3.2 Supply chain management market
5.19.3.3 Healthcare analytics market
5.19.3.4 Cloud ERP market
5.19.4 USER READINESS AND IMPACT ASSESSMENT
5.19.4.1 User readiness
5.19.4.1.1 User A: Manufacturers
5.19.4.1.2 User B: Distributors
5.19.4.1.3 User C: Providers
5.19.4.2 Impact assessment
5.19.4.2.1 User A: Manufacturers
5.19.4.2.1.1 Implementation
5.19.4.2.1.2 Impact
5.19.4.2.2 User B: Distributors
5.19.4.2.2.1 Implementation
5.19.4.2.2.2 Impact
5.19.4.2.3 User C: Providers
5.19.4.2.3.1 Implementation
5.19.4.2.3.2 Impact
6 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING
6.1 INTRODUCTION
6.2 SOFTWARE
6.2.1 ENTIRE SUPPLY CHAIN SUITES
6.2.1.1 Need for end-to-end visibility and real-time insights to drive market growth
6.2.2 SUPPLY CHAIN PLANNING SOFTWARE
6.2.2.1 Need for effective and efficient supply chain planning to fuel market growth
6.2.3 SUPPLIER RELATIONSHIP MANAGEMENT (SRM) SOFTWARE
6.2.3.1 Benefit of enhanced supplier collaboration to drive segmental growth
6.2.4 SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT SOFTWARE
6.2.4.1 Need for effective supply chain business network to boost market
6.2.5 SUPPLY CHAIN COST-TO-SERVE ANALYSIS SOFTWARE
6.2.5.1 Pressing need to cut costs and improve operational efficiency to drive growth
6.2.6 SUPPLY CHAIN ANALYTICS SOFTWARE
6.2.6.1 Advancements in artificial intelligence for data analytics to drive market growth
6.2.7 SUPPLY CHAIN VISIBILITY SOFTWARE
6.2.7.1 Greater visibility and maintenance across supply chain to drive market growth
6.3 HARDWARE
6.3.1 BARCODES & BARCODE SCANNERS
6.3.1.1 Need for better tracking and traceability of medical devices to drive market growth
6.3.2 SYSTEMS
6.3.2.1 Advantages of smart cabinets in effective inventory management to drive segment
6.3.3 RFID TAGS & READERS
6.3.3.1 Crucial role of RFIDs in asset tracking and inventory management to drive market growth
6.3.4 OTHER HARDWARE COMPONENTS
6.4 SERVICES
6.4.1 MANAGED SERVICES
6.4.1.1 Benefit of being able to focus on core business activities to drive demand for managed services
6.4.2 PROFESSIONAL SERVICES
6.4.2.1 Perks of running supply chains with expert advice to drive demand for professional services
7 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION
7.1 INTRODUCTION
7.2 PURCHASING MANAGEMENT
7.2.1 SUPPLY MANAGEMENT
7.2.1.1 Growing investments in supplier relationship management to boost market
7.2.2 PROCUREMENT
7.2.2.1 Need for optimized data storage and management to accelerate growth
7.2.3 CAPITAL PURCHASING
7.2.3.1 Increasing use by equipment providers, suppliers, and facilitators to foster growth
7.2.4 STRATEGIC SOURCING
7.2.4.1 Rising inclination toward data-driven decision making to aid growth
7.2.5 TRANSPORTATION MANAGEMENT
7.2.5.1 Increasing demand for streamlined logistics operations to sustain growth
7.3 INVENTORY MANAGEMENT
7.3.1 ORDER MANAGEMENT
7.3.1.1 Need for automated order fulfillment process to promote growth
7.3.2 WAREHOUSE MANAGEMENT
7.3.2.1 Rise in advancements in warehouse design and labor management to drive market
7.3.3 CONSIGNMENT MANAGEMENT
7.3.3.1 Growing demand for reduced supply chain expenses to boost market
7.3.4 IMPLANT MANAGEMENT
7.3.4.1 Need to track and trace implants to promote growth
7.3.5 TISSUE MANAGEMENT
7.3.5.1 Expanding applications of human tissue implants to spur growth
8 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED
8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS
8.2.1 SMALL-MOLECULE DRUGS
8.2.1.1 Need for efficient logistics to ensure timely delivery of small-molecule drugs to boost adoption of supply chain solutions
8.2.2 VACCINES
8.2.2.1 Need for robust infrastructure and advanced tracking systems to drive market growth
8.2.3 MONOCLONAL ANTIBODIES, BIOSIMILARS, AND MRNAS
8.2.3.1 New supply chain requirements fueled by ongoing advancements in biotechnology to support market growth
8.2.4 CELL & GENE THERAPY (CGT) PRODUCTS
8.2.4.1 Driving innovation in cell & gene therapy through strategic supply chain solutions to boost market
8.2.5 OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS
8.3 MEDICAL DEVICES & EQUIPMENT
8.3.1 SURGICAL INSTRUMENTS
8.3.1.1 Advancing surgical care through enhanced management of surgical instruments and logistics to contribute to growth
8.3.2 DIAGNOSTIC & THERAPEUTIC EQUIPMENT
8.3.2.1 Need for robust supply chain to handle complexities in diagnostic & therapeutic equipment to boost growth
8.3.3 MONITORING DEVICES
8.3.3.1 Growing need for effective supply chain management of monitoring devices to fuel growth
8.3.4 IMPLANTS & PROSTHETICS
8.3.4.1 Requirement of specialized manufacturing, sterilization, and distribution processes to propel market
8.3.5 OTHER MEDICAL DEVICES & EQUIPMENT
8.4 OTHER PRODUCTS MANAGED
9 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,
BY DEPLOYMENT MODEL
9.1 INTRODUCTION
9.2 ON-PREMISE MODELS
9.2.1 GROWING REQUIREMENT FOR DATA PRIVACY AND SECURITY TO DRIVE MARKET
9.3 CLOUD-BASED MODELS
9.3.1 NEED FOR COST-EFFECTIVE DATA SHARING TO STIMULATE GROWTH
10 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER
10.1 INTRODUCTION
10.1.1 MANUFACTURERS
10.1.1.1 Medical & surgical device manufacturers
10.1.1.1.1 Growing demand for advanced medical technologies to drive market
10.1.1.2 Pharmaceutical & biotechnology companies
10.1.1.2.1 Need to adhere to stringent regulatory requirements to augment growth
10.1.2 DISTRIBUTORS
10.1.2.1 Primary pharmaceutical distributors
10.1.2.1.1 Increasing focus on risk mitigation to speed up growth
10.1.2.2 Wholesalers
10.1.2.2.1 Growing complexity of global supply chain to fuel market
10.1.2.3 Group purchasing organizations
10.1.2.3.1 Rising need for simplified procurement process
to favor growth
10.1.3 HEALTHCARE PROVIDERS
10.1.3.1 Hospitals & clinics
10.1.3.1.1 Rising demand for improved patient outcomes
to facilitate growth
10.1.3.2 Pharmacies
10.1.3.2.1 Increasing reliance on barcode scanning and integrated software systems to aid growth
10.1.3.3 Ambulatory surgical centers
10.1.3.3.1 Need for effective inventory management to encourage growth
10.1.3.4 Other healthcare providers
11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Growing collaborations among market players to drive market
11.2.3 CANADA
11.2.3.1 Increasing adoption of digital technologies to promote growth
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Booming medical device market to propel market
11.3.3 UK
11.3.3.1 Growing health service initiatives by government bodies
to drive market
11.3.4 FRANCE
11.3.4.1 Evolving digital health landscape to augment growth
11.3.5 SPAIN
11.3.5.1 Rise in chronic diseases to encourage growth
11.3.6 ITALY
11.3.6.1 Increasing initiatives in pharmaceutical and healthcare sectors
to aid growth
11.3.7 NORDIC COUNTRIES
11.3.7.1 Rising healthcare expenditure to facilitate growth
11.3.8 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 JAPAN
11.4.2.1 Dominant aging population to accelerate growth
11.4.3 CHINA
11.4.3.1 Expanding healthcare infrastructure to fuel market
11.4.4 INDIA
11.4.4.1 Increasing healthcare access to spur growth
11.4.5 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Growing modernization efforts to propel market
11.5.3 MEXICO
11.5.3.1 Growing foreign investment to boost market
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Rising healthcare investments to facilitate growth
11.6.3 REST OF MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
12.3 REVENUE ANALYSIS, 2019–2023
12.4 MARKET SHARE ANALYSIS, 2023
12.4.1 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Offering footprint
12.5.5.4 Function footprint
12.5.5.5 End-user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.7.1 FINANCIAL METRICS
12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 SOLUTION/SERVICE LAUNCHES & ENHANCEMENTS
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 SAP SE
13.1.1.1 Business overview
13.1.1.2 Products/Services/Solutions offered
13.1.1.3 Recent developments
13.1.1.3.1 Solution enhancements
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 ORACLE
13.1.2.1 Business overview
13.1.2.2 Products/Services/Solutions offered
13.1.2.3 Recent developments
13.1.2.3.1 Solution enhancements
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 IBM
13.1.3.1 Business overview
13.1.3.2 Products/Services/Solutions offered
13.1.3.3 Recent developments
13.1.3.3.1 Deals
13.1.3.4 MnM view
13.1.3.4.1 Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 CARDINAL HEALTH
13.1.4.1 Business overview
13.1.4.2 Products/Services/Solutions offered
13.1.4.3 Recent developments
13.1.4.3.1 Deals
13.1.4.3.2 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Right to win
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 INFOR (KOCH INDUSTRIES)
13.1.5.1 Business overview
13.1.5.2 Products/Services/Solutions offered
13.1.5.3 Recent developments
13.1.5.3.1 Deals
13.1.5.4 MnM view
13.1.5.4.1 Right to win
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 MANHATTAN ASSOCIATES
13.1.6.1 Business overview
13.1.6.2 Products/Services/Solutions offered
13.1.7 TECSYS INC.
13.1.7.1 Business overview
13.1.7.2 Products/Services/Solutions offered
13.1.7.3 Recent developments
13.1.7.3.1 Solution enhancements
13.1.7.3.2 Deals
13.1.8 GLOBAL HEALTHCARE EXCHANGE, LLC
13.1.8.1 Business overview
13.1.8.2 Products/Services/Solutions offered
13.1.8.3 Recent developments
13.1.8.3.1 Service/Solution launches & enhancements
13.1.8.3.2 Deals
13.1.8.3.3 Expansions
13.1.9 EPICOR SOFTWARE CORPORATION
13.1.9.1 Business overview
13.1.9.2 Products/Services/Solutions offered
13.1.9.3 Recent developments
13.1.9.3.1 Software launches
13.1.9.3.2 Deals
13.1.10 CORCENTRIC, INC.
13.1.10.1 Business overview
13.1.10.2 Products/Services/Solutions offered
13.1.10.3 Recent developments
13.1.10.3.1 Deals
13.1.11 MCKESSON CORPORATION
13.1.11.1 Business overview
13.1.11.2 Products/Services/Solutions offered
13.1.11.3 Recent developments
13.1.11.3.1 Solution launches
13.1.11.3.2 Deals
13.1.12 COUPA
13.1.12.1 Business overview
13.1.12.2 Products/Services/Solutions offered
13.1.12.3 Recent developments
13.1.12.3.1 Solution launches
13.1.12.3.2 Deals
13.1.12.3.3 Expansions
13.1.13 BLUE YONDER GROUP, INC. (PANASONIC CORPORATION)
13.1.13.1 Business overview
13.1.13.2 Products/Services/Solutions offered
13.1.13.3 Recent developments
13.1.13.3.1 Product enhancements
13.1.13.3.2 Deals
13.1.14 LOGITAG SYSTEMS
13.1.14.1 Business overview
13.1.14.2 Products/Services/Solutions offered
13.1.15 PREMIER
13.1.15.1 Business overview
13.1.15.2 Products/Services/Solutions offered
13.1.15.3 Recent developments
13.1.15.3.1 Solution launches
13.1.15.3.2 Deals
13.1.16 WORKDAY, INC.
13.1.16.1 Business overview
13.1.16.2 Products/Services/Solutions offered
13.1.16.3 Recent developments
13.1.16.3.1 Solution launches
13.1.16.3.2 Deals
13.1.17 ARVATO SE (BERTELSMANN SE & CO. KGAA)
13.1.17.1 Business overview
13.1.17.2 Products/Services/Solutions offered
13.1.17.3 Recent developments
13.1.17.3.1 Deals
13.1.18 CENCORA, INC.
13.1.18.1 Business overview
13.1.18.2 Products/Services/Solutions offered
13.1.18.3 Recent developments
13.1.18.3.1 Service launches
13.1.18.3.2 Deals
13.1.18.3.3 Expansions
13.1.19 GEP
13.1.19.1 Business overview
13.1.19.2 Products/Services/Solutions offered
13.1.19.3 Recent developments
13.1.19.3.1 Solution launches
13.1.19.3.2 Deals
13.1.19.3.3 Expansions
13.2 OTHER PLAYERS
13.2.1 JUMP TECHNOLOGIES, INC.
13.2.2 MEDSPHERE SYSTEMS CORPORATION
13.2.3 PROMEDEO
13.2.4 PROCUREMENT PARTNERS
13.2.5 VIZIENT INC.
13.2.6 INBEAM TECHNOLOGIES
13.2.7 CONNECTSX
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key sources for secondary data
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Objectives of primary research
2.1.2.3 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.2.1 REVENUE SHARE ANALYSIS
2.2.2 BOTTOM-UP APPROACH (END-USER ADOPTION)
2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
2.2.4 TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET OVERVIEW
4.2 NORTH AMERICA: HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER & COUNTRY (2023)
4.3 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: GEOGRAPHIC SNAPSHOT
4.4 REGIONAL MIX: HEALTHCARE SUPPLY CHAIN MANAGEMENT (2024?2030)
4.5 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET: DEVELOPED VS. EMERGING MARKETS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing pressure on healthcare providers to improve operational efficiency and profitability
5.2.1.2 Rising demand for healthcare services due to population growth and aging demographics
5.2.1.3 Focus on reducing supply chain costs
5.2.1.4 Demand for transparency and traceability
5.2.1.5 Availability of funding, investments, and partnerships
5.2.1.6 Large-scale drug counterfeiting in pharmaceutical industry
5.2.2 RESTRAINTS
5.2.2.1 High implementation costs for advanced technologies
5.2.2.2 Data security and privacy concerns
5.2.2.3 Supply chain disruptions due to global events or geopolitical tensions
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing use of AI-powered solutions
5.2.3.2 Expansion into emerging markets with growing healthcare demands
5.2.3.3 Expansion of E-commerce in healthcare
5.2.3.4 Enhanced focus on sustainability and eco-friendly practices
in healthcare logistics
5.2.4 CHALLENGES
5.2.4.1 Complex and varying regulatory requirements across regions
5.2.4.2 Shortage of skilled professionals to manage sophisticated systems
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4 INDUSTRY TRENDS
5.4.1 ERP IN HEALTHCARE SUPPLY CHAIN MANAGEMENT SOLUTIONS
5.4.2 CLOUD-BASED SOLUTIONS
5.4.3 RISING STRATEGIC INITIATIVES AND INNOVATIONS BY KEY
INDUSTRY PLAYERS
5.5 ECOSYSTEM ANALYSIS
5.6 VALUE CHAIN ANALYSIS
5.7 TECHNOLOGY ANALYSIS
5.7.1 KEY TECHNOLOGIES
5.7.1.1 Blockchain
5.7.1.2 Artificial intelligence & machine learning
5.7.1.3 Cloud computing
5.7.2 COMPLEMENTARY TECHNOLOGIES
5.7.2.1 Data analytics
5.7.2.2 Internet of Things
5.7.3 ADJACENT TECHNOLOGIES
5.7.3.1 AR/VR
5.8 REGULATORY ANALYSIS
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
5.8.2 REGULATORY SCENARIO
5.8.3 INCREASING REGULATIONS AROUND CALIBRATION & CERTIFICATION
5.9 PRICING ANALYSIS
5.9.1 INDICATIVE PRICING OF SOLUTIONS, BY KEY PLAYER
5.9.2 AVERAGE SELLING PRICE, BY REGION (QUALITATIVE)
5.10 PORTER’S FIVE FORCES ANALYSIS
5.10.1 INTENSITY OF COMPETITIVE RIVALRY
5.10.2 BARGAINING POWER OF BUYERS
5.10.3 THREAT OF SUBSTITUTES
5.10.4 THREAT OF NEW ENTRANTS
5.10.5 BARGAINING POWER OF SUPPLIERS
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.11.2 KEY BUYING CRITERIA
5.12 PATENT ANALYSIS
5.12.1 PATENT PUBLICATION TRENDS
5.12.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR HEALTHCARE SUPPLY CHAIN MANAGEMENT
5.12.3 MAJOR PATENTS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
5.13 END-USER ANALYSIS
5.13.1 UNMET NEEDS
5.13.2 END-USER EXPECTATIONS
5.14 KEY CONFERENCES & EVENTS, 2024–2025
5.15 CASE STUDY ANALYSIS
5.15.1 CASE STUDY 1: TRANSFORMING SUPPLY CHAIN AT DAYTON
CHILDREN’S HOSPITAL
5.15.2 CASE STUDY 2: OLYMPUS CORPORATION’S PATH TO EFFICIENT HEALTHCARE SUPPLY CHAIN MANAGEMENT
5.15.3 CASE STUDY 3: IMPROVING SUPPLY CHAIN EFFICIENCY BY OVERCOMING FORECASTING AND INVENTORY BARRIERS
5.16 INVESTMENT AND FUNDING SCENARIO
5.17 BUSINESS MODELS
5.18 TRADE ANALYSIS
5.18.1 IMPORT SCENARIO FOR HS CODE 847190
5.18.2 EXPORT SCENARIO FOR HS CODE 847190
5.19 IMPACT OF AI/GEN AI ON HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
5.19.1 KEY USE CASES
5.19.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
5.19.2.1 Case Study 1: Enhancing supply chain with AI solutions at NHS Blood and Transplant
5.19.2.2 Case Study 2: Leveraging AI for proactive infection prevention in hospitals
5.19.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
5.19.3.1 Healthcare IT market
5.19.3.2 Supply chain management market
5.19.3.3 Healthcare analytics market
5.19.3.4 Cloud ERP market
5.19.4 USER READINESS AND IMPACT ASSESSMENT
5.19.4.1 User readiness
5.19.4.1.1 User A: Manufacturers
5.19.4.1.2 User B: Distributors
5.19.4.1.3 User C: Providers
5.19.4.2 Impact assessment
5.19.4.2.1 User A: Manufacturers
5.19.4.2.1.1 Implementation
5.19.4.2.1.2 Impact
5.19.4.2.2 User B: Distributors
5.19.4.2.2.1 Implementation
5.19.4.2.2.2 Impact
5.19.4.2.3 User C: Providers
5.19.4.2.3.1 Implementation
5.19.4.2.3.2 Impact
6 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY OFFERING
6.1 INTRODUCTION
6.2 SOFTWARE
6.2.1 ENTIRE SUPPLY CHAIN SUITES
6.2.1.1 Need for end-to-end visibility and real-time insights to drive market growth
6.2.2 SUPPLY CHAIN PLANNING SOFTWARE
6.2.2.1 Need for effective and efficient supply chain planning to fuel market growth
6.2.3 SUPPLIER RELATIONSHIP MANAGEMENT (SRM) SOFTWARE
6.2.3.1 Benefit of enhanced supplier collaboration to drive segmental growth
6.2.4 SUPPLY CHAIN BUSINESS NETWORK MANAGEMENT SOFTWARE
6.2.4.1 Need for effective supply chain business network to boost market
6.2.5 SUPPLY CHAIN COST-TO-SERVE ANALYSIS SOFTWARE
6.2.5.1 Pressing need to cut costs and improve operational efficiency to drive growth
6.2.6 SUPPLY CHAIN ANALYTICS SOFTWARE
6.2.6.1 Advancements in artificial intelligence for data analytics to drive market growth
6.2.7 SUPPLY CHAIN VISIBILITY SOFTWARE
6.2.7.1 Greater visibility and maintenance across supply chain to drive market growth
6.3 HARDWARE
6.3.1 BARCODES & BARCODE SCANNERS
6.3.1.1 Need for better tracking and traceability of medical devices to drive market growth
6.3.2 SYSTEMS
6.3.2.1 Advantages of smart cabinets in effective inventory management to drive segment
6.3.3 RFID TAGS & READERS
6.3.3.1 Crucial role of RFIDs in asset tracking and inventory management to drive market growth
6.3.4 OTHER HARDWARE COMPONENTS
6.4 SERVICES
6.4.1 MANAGED SERVICES
6.4.1.1 Benefit of being able to focus on core business activities to drive demand for managed services
6.4.2 PROFESSIONAL SERVICES
6.4.2.1 Perks of running supply chains with expert advice to drive demand for professional services
7 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY FUNCTION
7.1 INTRODUCTION
7.2 PURCHASING MANAGEMENT
7.2.1 SUPPLY MANAGEMENT
7.2.1.1 Growing investments in supplier relationship management to boost market
7.2.2 PROCUREMENT
7.2.2.1 Need for optimized data storage and management to accelerate growth
7.2.3 CAPITAL PURCHASING
7.2.3.1 Increasing use by equipment providers, suppliers, and facilitators to foster growth
7.2.4 STRATEGIC SOURCING
7.2.4.1 Rising inclination toward data-driven decision making to aid growth
7.2.5 TRANSPORTATION MANAGEMENT
7.2.5.1 Increasing demand for streamlined logistics operations to sustain growth
7.3 INVENTORY MANAGEMENT
7.3.1 ORDER MANAGEMENT
7.3.1.1 Need for automated order fulfillment process to promote growth
7.3.2 WAREHOUSE MANAGEMENT
7.3.2.1 Rise in advancements in warehouse design and labor management to drive market
7.3.3 CONSIGNMENT MANAGEMENT
7.3.3.1 Growing demand for reduced supply chain expenses to boost market
7.3.4 IMPLANT MANAGEMENT
7.3.4.1 Need to track and trace implants to promote growth
7.3.5 TISSUE MANAGEMENT
7.3.5.1 Expanding applications of human tissue implants to spur growth
8 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY PRODUCT MANAGED
8.1 INTRODUCTION
8.2 PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS
8.2.1 SMALL-MOLECULE DRUGS
8.2.1.1 Need for efficient logistics to ensure timely delivery of small-molecule drugs to boost adoption of supply chain solutions
8.2.2 VACCINES
8.2.2.1 Need for robust infrastructure and advanced tracking systems to drive market growth
8.2.3 MONOCLONAL ANTIBODIES, BIOSIMILARS, AND MRNAS
8.2.3.1 New supply chain requirements fueled by ongoing advancements in biotechnology to support market growth
8.2.4 CELL & GENE THERAPY (CGT) PRODUCTS
8.2.4.1 Driving innovation in cell & gene therapy through strategic supply chain solutions to boost market
8.2.5 OTHER PHARMACEUTICAL & BIOTECHNOLOGY PRODUCTS
8.3 MEDICAL DEVICES & EQUIPMENT
8.3.1 SURGICAL INSTRUMENTS
8.3.1.1 Advancing surgical care through enhanced management of surgical instruments and logistics to contribute to growth
8.3.2 DIAGNOSTIC & THERAPEUTIC EQUIPMENT
8.3.2.1 Need for robust supply chain to handle complexities in diagnostic & therapeutic equipment to boost growth
8.3.3 MONITORING DEVICES
8.3.3.1 Growing need for effective supply chain management of monitoring devices to fuel growth
8.3.4 IMPLANTS & PROSTHETICS
8.3.4.1 Requirement of specialized manufacturing, sterilization, and distribution processes to propel market
8.3.5 OTHER MEDICAL DEVICES & EQUIPMENT
8.4 OTHER PRODUCTS MANAGED
9 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET,
BY DEPLOYMENT MODEL
9.1 INTRODUCTION
9.2 ON-PREMISE MODELS
9.2.1 GROWING REQUIREMENT FOR DATA PRIVACY AND SECURITY TO DRIVE MARKET
9.3 CLOUD-BASED MODELS
9.3.1 NEED FOR COST-EFFECTIVE DATA SHARING TO STIMULATE GROWTH
10 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY END USER
10.1 INTRODUCTION
10.1.1 MANUFACTURERS
10.1.1.1 Medical & surgical device manufacturers
10.1.1.1.1 Growing demand for advanced medical technologies to drive market
10.1.1.2 Pharmaceutical & biotechnology companies
10.1.1.2.1 Need to adhere to stringent regulatory requirements to augment growth
10.1.2 DISTRIBUTORS
10.1.2.1 Primary pharmaceutical distributors
10.1.2.1.1 Increasing focus on risk mitigation to speed up growth
10.1.2.2 Wholesalers
10.1.2.2.1 Growing complexity of global supply chain to fuel market
10.1.2.3 Group purchasing organizations
10.1.2.3.1 Rising need for simplified procurement process
to favor growth
10.1.3 HEALTHCARE PROVIDERS
10.1.3.1 Hospitals & clinics
10.1.3.1.1 Rising demand for improved patient outcomes
to facilitate growth
10.1.3.2 Pharmacies
10.1.3.2.1 Increasing reliance on barcode scanning and integrated software systems to aid growth
10.1.3.3 Ambulatory surgical centers
10.1.3.3.1 Need for effective inventory management to encourage growth
10.1.3.4 Other healthcare providers
11 HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
11.2.2 US
11.2.2.1 Growing collaborations among market players to drive market
11.2.3 CANADA
11.2.3.1 Increasing adoption of digital technologies to promote growth
11.3 EUROPE
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
11.3.2 GERMANY
11.3.2.1 Booming medical device market to propel market
11.3.3 UK
11.3.3.1 Growing health service initiatives by government bodies
to drive market
11.3.4 FRANCE
11.3.4.1 Evolving digital health landscape to augment growth
11.3.5 SPAIN
11.3.5.1 Rise in chronic diseases to encourage growth
11.3.6 ITALY
11.3.6.1 Increasing initiatives in pharmaceutical and healthcare sectors
to aid growth
11.3.7 NORDIC COUNTRIES
11.3.7.1 Rising healthcare expenditure to facilitate growth
11.3.8 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
11.4.2 JAPAN
11.4.2.1 Dominant aging population to accelerate growth
11.4.3 CHINA
11.4.3.1 Expanding healthcare infrastructure to fuel market
11.4.4 INDIA
11.4.4.1 Increasing healthcare access to spur growth
11.4.5 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
11.5.2 BRAZIL
11.5.2.1 Growing modernization efforts to propel market
11.5.3 MEXICO
11.5.3.1 Growing foreign investment to boost market
11.5.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
11.6.2 GCC COUNTRIES
11.6.2.1 Rising healthcare investments to facilitate growth
11.6.3 REST OF MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN HEALTHCARE SUPPLY CHAIN MANAGEMENT MARKET
12.3 REVENUE ANALYSIS, 2019–2023
12.4 MARKET SHARE ANALYSIS, 2023
12.4.1 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Region footprint
12.5.5.3 Offering footprint
12.5.5.4 Function footprint
12.5.5.5 End-user footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.7.1 FINANCIAL METRICS
12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 SOLUTION/SERVICE LAUNCHES & ENHANCEMENTS
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 SAP SE
13.1.1.1 Business overview
13.1.1.2 Products/Services/Solutions offered
13.1.1.3 Recent developments
13.1.1.3.1 Solution enhancements
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses & competitive threats
13.1.2 ORACLE
13.1.2.1 Business overview
13.1.2.2 Products/Services/Solutions offered
13.1.2.3 Recent developments
13.1.2.3.1 Solution enhancements
13.1.2.3.2 Deals
13.1.2.3.3 Expansions
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses & competitive threats
13.1.3 IBM
13.1.3.1 Business overview
13.1.3.2 Products/Services/Solutions offered
13.1.3.3 Recent developments
13.1.3.3.1 Deals
13.1.3.4 MnM view
13.1.3.4.1 Right to win
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses & competitive threats
13.1.4 CARDINAL HEALTH
13.1.4.1 Business overview
13.1.4.2 Products/Services/Solutions offered
13.1.4.3 Recent developments
13.1.4.3.1 Deals
13.1.4.3.2 Expansions
13.1.4.4 MnM view
13.1.4.4.1 Right to win
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses & competitive threats
13.1.5 INFOR (KOCH INDUSTRIES)
13.1.5.1 Business overview
13.1.5.2 Products/Services/Solutions offered
13.1.5.3 Recent developments
13.1.5.3.1 Deals
13.1.5.4 MnM view
13.1.5.4.1 Right to win
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses & competitive threats
13.1.6 MANHATTAN ASSOCIATES
13.1.6.1 Business overview
13.1.6.2 Products/Services/Solutions offered
13.1.7 TECSYS INC.
13.1.7.1 Business overview
13.1.7.2 Products/Services/Solutions offered
13.1.7.3 Recent developments
13.1.7.3.1 Solution enhancements
13.1.7.3.2 Deals
13.1.8 GLOBAL HEALTHCARE EXCHANGE, LLC
13.1.8.1 Business overview
13.1.8.2 Products/Services/Solutions offered
13.1.8.3 Recent developments
13.1.8.3.1 Service/Solution launches & enhancements
13.1.8.3.2 Deals
13.1.8.3.3 Expansions
13.1.9 EPICOR SOFTWARE CORPORATION
13.1.9.1 Business overview
13.1.9.2 Products/Services/Solutions offered
13.1.9.3 Recent developments
13.1.9.3.1 Software launches
13.1.9.3.2 Deals
13.1.10 CORCENTRIC, INC.
13.1.10.1 Business overview
13.1.10.2 Products/Services/Solutions offered
13.1.10.3 Recent developments
13.1.10.3.1 Deals
13.1.11 MCKESSON CORPORATION
13.1.11.1 Business overview
13.1.11.2 Products/Services/Solutions offered
13.1.11.3 Recent developments
13.1.11.3.1 Solution launches
13.1.11.3.2 Deals
13.1.12 COUPA
13.1.12.1 Business overview
13.1.12.2 Products/Services/Solutions offered
13.1.12.3 Recent developments
13.1.12.3.1 Solution launches
13.1.12.3.2 Deals
13.1.12.3.3 Expansions
13.1.13 BLUE YONDER GROUP, INC. (PANASONIC CORPORATION)
13.1.13.1 Business overview
13.1.13.2 Products/Services/Solutions offered
13.1.13.3 Recent developments
13.1.13.3.1 Product enhancements
13.1.13.3.2 Deals
13.1.14 LOGITAG SYSTEMS
13.1.14.1 Business overview
13.1.14.2 Products/Services/Solutions offered
13.1.15 PREMIER
13.1.15.1 Business overview
13.1.15.2 Products/Services/Solutions offered
13.1.15.3 Recent developments
13.1.15.3.1 Solution launches
13.1.15.3.2 Deals
13.1.16 WORKDAY, INC.
13.1.16.1 Business overview
13.1.16.2 Products/Services/Solutions offered
13.1.16.3 Recent developments
13.1.16.3.1 Solution launches
13.1.16.3.2 Deals
13.1.17 ARVATO SE (BERTELSMANN SE & CO. KGAA)
13.1.17.1 Business overview
13.1.17.2 Products/Services/Solutions offered
13.1.17.3 Recent developments
13.1.17.3.1 Deals
13.1.18 CENCORA, INC.
13.1.18.1 Business overview
13.1.18.2 Products/Services/Solutions offered
13.1.18.3 Recent developments
13.1.18.3.1 Service launches
13.1.18.3.2 Deals
13.1.18.3.3 Expansions
13.1.19 GEP
13.1.19.1 Business overview
13.1.19.2 Products/Services/Solutions offered
13.1.19.3 Recent developments
13.1.19.3.1 Solution launches
13.1.19.3.2 Deals
13.1.19.3.3 Expansions
13.2 OTHER PLAYERS
13.2.1 JUMP TECHNOLOGIES, INC.
13.2.2 MEDSPHERE SYSTEMS CORPORATION
13.2.3 PROMEDEO
13.2.4 PROCUREMENT PARTNERS
13.2.5 VIZIENT INC.
13.2.6 INBEAM TECHNOLOGIES
13.2.7 CONNECTSX
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
